Vetmedin-CA1 (Pimobendan) Chewable Tablets for Dogs

Vetmedin-CA1 (Pimobendan) Chewable Tablets for Dogs
1.25 mg, Single - chewable tablet
1.25 mg, 50 count - chewable tablets
5 mg, Single - chewable tablet
5 mg, 50 count - chewable tablets
SKU : 135125_-RX
Price: $1.11
Price: $1.11

Veterinarian Prescription (Rx) Required
Free Shipping on orders over $75 
Low Price Match Guarantee

Treat myxomatous mitral valve disease (MMVD) even sooner with VETMEDIN®-CA1 (pimobendan) Chewable Tablets!

  • Used to delay of onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease
  • Stage B2 preclinical myxomatous mitral valve disease (MMVD) refers to dogs with asymptomatic MMVD that have a moderate or loud mitral murmur due to mitral regurgitation and cardiomegaly
  • Pimobendan
  • Chewable Tablets

Click here for the Original Vetmedin!

How to Order Prescriptions

Description

VETMEDIN-CA1 (pimobendan) is indicated for the delay of onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease (2019 ACVIM Consensus Statement1 ).

Stage B2 preclinical myxomatous mitral valve disease (MMVD) refers to dogs with asymptomatic MMVD that have a moderate or loud mitral murmur due to mitral regurgitation and cardiomegaly.

Dosage and Administration

Always provide the Client Information Sheet to the dog owner with each prescription.

VETMEDIN-CA1 should be administered orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight, using a suitable combination of whole or half tablets. The total daily dose should be divided into 2 portions that are not necessarily equal, and the portions should be administered approximately 12 hours apart (i.e., morning and evening). The tablets are scored, and the calculated dosage should be provided to the nearest half tablet increment.

Contraindications

Do not administer VETMEDIN-CA1 in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons.

Do not administer VETMEDIN-CA1 to dogs with Stage A or B1 preclinical MMVD (2019 ACVIM Consensus Statement) due to the risk of cardiac pathology associated with exaggerated hemodynamic responses to VETMEDIN-CA1.

Human Warnings

Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans.

Animal Warnings

Keep VETMEDIN-CA1 in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.

At 3 and 5 times the recommended dosage, administered over a 6-month period of time, pimobendan caused an exaggerated hemodynamic response in the normal dog heart, which was associated with cardiac pathology.

Storage Information

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (between 59° and 86°F)
Loading...